In summary, this research describes a novel SEMA3B‐AS1–EP300–SEMA3B–NRP1 axis and unravels the potential molecular mechanisms of lncRNA SEMA3B‐AS1 in CRC progression, providing novel ideas for the diagnosis and treatment of CRC. This evidence concerns the gene SEMA3B and colorectal carcinoma.